Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography

The present study included 760 patients who were referred to elective coronary angiography. Data were recorded by standardized interviews and by standardized examination protocols at our institution and were extracted from medical records. Serum GPC4 levels were measured with a commercially available ELSIA kit. During a follow up period the incidence of MACE, vascular mortality, and all-cause mortality were recorded. The Table includes baseline characteristics and GPC4 values as well as the endpoints major adverse cardiovascular events, vascular mortality, and all-cause mortality occurred during the follow-up period. GPC4 is given as ng/ml as well as z-transformed variable. Furthermore, GPC4 was categorized according to the optimal predictive cut-off value for GPC4. “Sex” describes the biological sex of subjects, whereas “0” stands for “male” and “1” for “female” patients. For other categorical variables“0” encodes “no” and “1” stands for “yes”.

本研究纳入760名接受择期冠状动脉造影（elective coronary angiography）的患者。研究数据通过标准化访谈、本机构的标准化检查方案采集，并从病历中提取。血清GPC4（GPC4）水平采用市售ELSIA试剂盒检测。随访期间，记录了主要不良心血管事件（Major Adverse Cardiovascular Events, MACE）、血管性死亡及全因死亡的发生率。本表格收录了受试者的基线特征、GPC4水平，以及随访期间发生的主要不良心血管事件、血管性死亡与全因死亡等终点事件数据。GPC4水平以ng/ml为单位给出，同时提供经Z变换后的变量值。此外，本研究依据GPC4的最优预测截断值对其进行分组。"性别（Sex）"指代受试者的生物学性别，其中"0"代表男性患者，"1"代表女性患者。其余分类变量中，"0"编码为"否"，"1"代表"是"。